In particular, high levels of BMI1, an oncogene highly expressed in acute myeloid leukemia and in advanced phases of CML, were connected to a poorer outcome, whereas on the other side a high expression of CBX6 and CBX7 played a favorable role (16). Here, CBX6 is linked to acute myeloid leukemia.